Has the therapeutical ceiling been reached in Crohn's disease randomized controlled trials? A systematic review and meta‐analysis

BACKGROUND AND AIMS: The availability of biological agents for inflammatory bowel disease has increased over the past years. In this systematic review and meta‐analysis, we aimed to explore time trends in clinical response and clinical remission rates in Crohn's disease (CD) patients treated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Magro, Fernando, Moreira, Paula Leão, Catalano, Gaia, Alves, Catarina, Roseira, Joana, Estevinho, Maria Manuela, Silva, Isabel, Dignass, Axel, Peyrin‐Biroulet, Laurent, Danese, Silvio, Jairath, Vipul, Dias, Claudia Camila, Santiago, Mafalda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039796/
https://www.ncbi.nlm.nih.gov/pubmed/36876515
http://dx.doi.org/10.1002/ueg2.12366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039796/
https://www.ncbi.nlm.nih.gov/pubmed/36876515
http://dx.doi.org/10.1002/ueg2.12366

Ejemplares similares